Statistics

Total Visits

Views
The JAK inhibitor tofacitinib for active rheumatoid arthritis: Results from Phase III trials21

Select a period of time:

Number of views in the range

Views
The JAK inhibitor tofacitinib for active rheumatoid arthritis: Results from Phase III trials10

Views

Views
May 20246
June 20242
July 20241
August 20241
September 20240
October 20240
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
 

Top cities views

Views
Chicago2
Gallatin1